Stock Trading Canary

United States · SEC Form 4 · Snapshot date: 2026-10-18 · Built: 2026-10-18 · 中文

← United States · Coverage record

US · SEC FORM 4

BECTON DICKINSON & CO

BDX · NYSE · CIK 0000010795 · Healthcare · Medical Instruments & Supplies

INSIDER SIGNAL

No active buy signal

0 qualifying P purchase groups
in the current 180-day scoring window

21 Form 4 transaction lines observed in the same window
11 sales · 10 option, withholding, award, gift or other lines

Last qualifying purchase2025-08-11 · HAYES GREGORY · $1.0M

WHY NO ACTIVE SIGNAL?

Purchase activityNone
Recent buyingNone
Recent salesModerate
Buy signal statusInactive
Score anatomy

No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.

ClusterNot calculated
Purchase sizeNot calculated
RoleNot calculated
RecencyNot calculated
ConvictionNot calculated

Why is there no score?

  • No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
  • Sales and other Form 4 activity remain visible as context and do not create a negative score.

Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.

Insider activity timeline

Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.

AprMayJunJulAugSepOct
Feld MichaelEVP, Chief Revenue Officer
▼▼▼▼○▼▼
Polen Thomas E JrChairman, CEO and President
○○▼○○▼
Garrison Michael DavidEVP & Pres Med.Essntl&BioPharm
▼▼
Roque VitorEVP & Chief Financial Officer
○○
Muhsin BilalEVP & President Connected Care
○○
Menziuso PeterEVP and President, BDI
○
● Purchase▼ Sale○ Other

Showing the six most active owners; 1 additional owner(s) remain in Form 4 evidence.

Purchase breadth, concentration & cluster buying

These modules activate when qualifying purchases enter the 180-day research window.

SIGNAL HISTORY

No recorded active-signal snapshot

Scores are archived only when the company qualifies for a published US buy-signal snapshot. Last qualifying purchase: 2025-08-11 · HAYES GREGORY.

Recent Form 4 activity

0Purchases
22Sales
56Other Form 4 lines
56SEC filings · 365 days
BUYING0 qualifying P line(s) · 180 days
SELLING11 sale line(s) · context only
OTHER10 exercise / withholding / award / gift / other lines
10b5-1 / PLANNEDNot assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

Market context

Market context provides additional background on recent price performance and risk. It does not affect the Insider Signal.

Price performance

1M
-4.2%
3M
+17.8%
6M
+14.6%
12M
—

Volatility & liquidity

Volatility
25.9%
Beta
—
Avg daily value
—

Valuation

Market cap
—
P/E
—

Fundamentals

Profit margin
7.7%
ROE
6.6%
Industry
Medical Instruments & Supplies

Market data

Price data up to: 2026-09-30 · Price source: OpenBB/yfinance · From SEC filings: Profit margin, ROE · Fiscal year ended: 2025-09-30 · Status: PASS

Short interest

Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.

Shares short
9,775,719
Previous report
11,316,237
Avg daily volume
2,002,996
Days to cover
4.9

FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.

Historical equity purchases

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting ownerTypeSecuritySharesAvg. priceApprox. valueSource
2025-08-11HAYES GREGORYPurchase (P)Common Stock5,250USD 191.57USD 1,005,742SEC filing ↗
2025-02-10Henderson Jeffrey WilliamPurchase (P)Common Stock1,500USD 233.62USD 350,430SEC filing ↗

Form 4 evidence

78 transaction lines in the latest 365-day window; 537 in local history.

DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-09-28Feld MichaelSale (S)Common Stock76USD 183.70USD 13,961SEC filing ↗
2026-09-02Roque VitorTax withholding (F)Common Stock190USD 0.00USD 0SEC filing ↗
2026-08-26Feld MichaelSale (S)Common Stock165USD 188.49USD 31,101SEC filing ↗
Show recent Form 4 evidence (30 grouped rows)
DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-09-28Feld MichaelSale (S)Common Stock76USD 183.70USD 13,961SEC filing ↗
2026-09-02Roque VitorTax withholding (F)Common Stock190USD 0.00USD 0SEC filing ↗
2026-08-26Feld MichaelSale (S)Common Stock165USD 188.49USD 31,101SEC filing ↗
2026-08-20Feld MichaelTax withholding (F)Common Stock1,049USD 0.00USD 0SEC filing ↗
2026-08-13Polen Thomas E JrSale (S)Common Stock4,152USD 185.00USD 768,120SEC filing ↗
2026-08-13Polen Thomas E JrOption exercise / conversion (M)Common Stock43,278USD 167.25USD 7,238,246SEC filing ↗
2026-08-13Polen Thomas E JrD (D)Common Stock39,126USD 185.00USD 7,238,310SEC filing ↗
2026-08-11Goette RolandSale (S)Common Stock2,438USD 180.84USD 440,888SEC filing ↗
2026-07-27Feld MichaelSale (S)Common Stock75USD 157.13USD 11,785SEC filing ↗
2026-07-02Muhsin BilalTax withholding (F)Common Stock1,935USD 0.00USD 0SEC filing ↗
2026-07-01Muhsin BilalAward / grant (A)Common Stock14,342USD 0.00USD 0SEC filing ↗
2026-06-26Feld MichaelSale (S)Common Stock75USD 152.80USD 11,460SEC filing ↗
2026-06-24Garrison Michael DavidSale (S)Common Stock1,100USD 145.66USD 160,226SEC filing ↗
2026-06-10Garrison Michael DavidSale (S)Common Stock1,100USD 151.48USD 166,628SEC filing ↗
2026-06-01Polen Thomas E JrSale (S)Common Stock2,764USD 146.35USD 404,511SEC filing ↗
2026-06-01Polen Thomas E JrOption exercise / conversion (M)Common Stock20,209USD 126.16USD 2,549,567SEC filing ↗
2026-06-01Polen Thomas E JrD (D)Common Stock17,445USD 146.15USD 2,549,587SEC filing ↗
2026-06-01Menziuso PeterAward / grant (A)Common Stock14,258USD 0.00USD 0SEC filing ↗
2026-05-26Feld MichaelSale (S)Common Stock75USD 147.35USD 11,051SEC filing ↗
2026-05-07Roque VitorAward / grant (A)Common Stock1,721USD 0.00USD 0SEC filing ↗
2026-04-27Feld MichaelSale (S)Common Stock74USD 151.94USD 11,244SEC filing ↗
2026-04-06Neal Shana CarolTax withholding (F)Common Stock1,146USD 0.00USD 0SEC filing ↗
2026-03-26Feld MichaelSale (S)Common Stock75USD 156.83USD 11,762SEC filing ↗
2026-03-16Minnix LaneshaAward / grant (A)Common Stock7,492USD 0.00USD 0SEC filing ↗
2026-03-02Spikner Pamela L.Award / grant (A)Common Stock931USD 0.00USD 0SEC filing ↗
2026-03-02Roque VitorAward / grant (A)Common Stock931USD 0.00USD 0SEC filing ↗
2026-02-26Feld MichaelSale (S)Common Stock75USD 181.84USD 13,638SEC filing ↗
2026-02-18SCOTT BERTRAM LSale (S)Common Stock953USD 182.61USD 174,027SEC filing ↗
2026-01-27Wright JacquelineAward / grant (A)Common Stock1,098USD 0.00USD 0SEC filing ↗
2026-01-27Waldstreicher JoanneAward / grant (A)Common Stock1,098USD 0.00USD 0SEC filing ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

Snapshot & identity

Snapshot date2026-10-18
Ranking versionUS-v1.2
Data qualityPASS ELIGIBLE · —
TickerBDX
CIK0000010795
SectorHealthcare
IndustryMedical Instruments & Supplies Yahoo Finance
SEC SIC3841 Surgical & Medical Instruments & Apparatus
ExchangeNYSE

Data coverage

Local Form 4 history537 transaction lines from 2020-01-01 to 2026-09-28
2 P purchase lines · 111 S sale lines · 424 other lines
SEC company submissionsOpen SEC filings ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.